Skip to Main Content

Paper Details

Concerns about the use of polygenic embryo screening for psychiatric and cognitive traits.
Lancet Psychiatry
12
2022
complex diseases, embryo, embryos, psychiatric disorders
Author NameAffiliation
Todd LenczZucker Hillside Hospital, The Zucker Hillside Hospital Division of Northwell Health, USA Institute for Behavioral Science, The Feinstein Institutes for Medical Research
Maya SabatelloDivision of Ethics, Department of Medical Humanities and Ethics, Columbia University
Anna R DochertyUniversity of Utah School of Medicine
Laura J BierutWashington University School of Medicine
David CurtisUCL Genetics Institute, University College London
Franziska DegenhardtUniversity Hospital Essen, University of Duisburg-Essen
Laura M HuckinsIcahn School of Medicine at Mount Sinai
Manuel MattheisenDalhousie Medical School
Bettina MeiserPrince of Wales Clinical School, University of New South Wales
Marcella RietschelCentral Institute of Mental Health, Heidelberg University
Lea K DavisVanderbilt Genetics Institute, Vanderbilt University Medical Center
  • 1 - 11

Datasets